Medical Marijuana, Inc. Subsidiary HempMeds® Brasil’s Sold-Out Doctor Symposium on Medical Cannabis Garners Vast Media Coverage Across Brazil

by adminTorusBrand | Aug 23, 2017 | HempMeds Brasil, Press Releases

SAN DIEGO, Aug. 23, 2017  — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil held a successful, sold-out Doctor Symposium in Sao Paulo, Brazil on August 15, with...

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Its Second Doctor Symposium on Medical Cannabis in Sao Paulo, Brazil

by adminTorusBrand | Aug 14, 2017 | HempMeds Brasil, Press Releases

Sold-Out Event to Educate Brazilian Medical Community on Therapeutic Uses of Cannabis, Importation and Prescribing Rules to Provide Patients Greater Access SAN DIEGO, Aug. 14, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company...

HempMeds® Brasil Featured as Educational Source for Brasilians Exploring CBD

by adminTorusBrand | Aug 11, 2017 | HempMeds Brasil, Media Coverage

[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. portfolio company HempMeds® Brasil was featured this week in an article about CBD oil’s growing use among patients on the nation’s popular Catraquinha website. According to the Catraquinha website, the page,...

The CBD Hemp Oil Movement – and Medical Marijuana, Inc.’s place in it.

by adminTorusBrand | Aug 2, 2017 | Axim Biotechnologies, Company News, Dixie Botanicals, HempMeds, HempMeds Brasil, HempMeds Mexico

[vc_row][vc_column][vc_column_text]Since 2012, Mediccal Marijuana, Inc. has been recognized as an industry leader in the CBD hemp oil space. As the first company in the world to develop nationally legal CBD hemp oil products, Medical Marijuana, Inc. pioneered the path...

Medical Marijuana, Inc. and Subsidiary HempMeds Brasil™ Garners Vast Media Coverage Across Brazil of Company and Cannabis Market Growth

by adminTorusBrand | Jul 20, 2017 | HempMeds Brasil, Press Releases

SAN DIEGO, July 20, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that it and its subsidiary HempMeds® Brasil garnered extensive media coverage across Brazil about the...

Amyotrophic Lateral Sclerosis (ALS) and Psoriasis Patients Receive Brazilian Government Permission to Be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

by adminTorusBrand | Jul 19, 2017 | HempMeds Brasil, Press Releases

Brazilian Doctors Have Been Prescribing RSHO™ to Treat Patients Suffering From Effects of ALS and Psoriasis SAN DIEGO, July 19, 2017 — Medical Marijuana, Inc. (MJNA) is the first publicly traded cannabis company in the United States. Its subsidiary HempMeds®...